Substance P receptor expression in human skin keratinocytes and fibroblasts

British Journal of Dermatology

Volumn 155, Issue 4, 2006, Pages 657-662

  Liu, J Y ^a   Hu, J H ^a   Zhu, Q G ^a   Li, F Q ^a   Sun, H J ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cutaneous allergic inflammation; Fibroblast; HaCaT cell line; Keratinocyte; Substance P receptor

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; SPANTIDE; SUBSTANCE P RECEPTOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; EPIDERMIS CELL; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN ALLERGY; SKIN INFLAMMATION; UPREGULATION; WESTERN BLOTTING;

CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERON TYPE II; INTERFERON-GAMMA; KERATINOCYTES; RECEPTORS, NEUROKININ-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; SUBSTANCE P;

EID: 33748466944     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07408.x     Document Type: Article

References (31)

1. Luger TA. Neuromediators - a crucial component of the skin immune system. J Dermatol Sci 2002; 30:87-93.
2. O'Sullivan RL, Lipper G, Lerner EA. The neuro-immuno-cutaneous-endocrine network: relationship of mind and skin. Arch Dermatol 1998; 134:1431-5.
3. Quartara L, Maggi CA. The tachykinin NK-1 receptor. Part II: distribution and pathophysiological roles. Neuropeptides 1998; 32:1-49.
4. Bockmann S. Substance P (NK-1) receptor expression by human colonic epithelial cell line Caco-2. Peptides 2002; 23:1783-91.
5. Kyu HK, Kyoung CP, Jin HC et al. The effect of substance P on peripheral blood mononuclear cells in patients with atopic dermatitis. J Dermatol Sci 2003; 32:115-24.
6. Seiffert K, Granstein RD. Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. Methods 2002; 28:97-103.
7. Staniek V, Doutremepuich JD, Schmitt D et al. Expression of substance P receptors in normal and psoriatic skin. Pathobiology 1999; 67:51-4.
8. Park YM, Kim CW. The effects of substance P and vasoactive intestinal peptide on interleukin-6 synthesis in cultured human keratinocytes. J Dermatol Sci 1999; 22:17-23.
9. Yu B, Koga T, Urabe K et al. Differential regulation of thymus- and activation-regulated chemokine induced by IL-4, IL-3, TNF-α and IFN-γ in human keratinocyte and fibroblast. J Dermatol Sci 2002; 30:29-36.
10. Okabe T, Hide M, Koro O et al. Substance P induces tumor necrosis factor-α release from human skin via mitogen-activated protein kinase. Eur J Pharmacol 2000; 398:309-15.
11. Zhu Q, Hu J, Fan G et al. Study on metabolism of ketoprofen isopropyl ester in HaCaT cells. Chin Pharm J 2003; 38:22-5.
12. Zhu Q, Hu J, Fan G et al. Metabolism of ketoprofen isopropyl ester in skin cells. Chin Hosp Pharm J 2002; 22:195-7.
13. Kumagai N, Fukuda K, Fujitsu Y, Nishida T. Expression of functional ICAM-1 on cultured human keratocytes induced by tumor necrosis factor-α. Jpn J Ophthalmol 2003; 47:134-41.
14. Lai J, Douglas SD, Zhao M et al. Human lymphocytes express substance P and its receptor. J Neuroimmunol 1998; 86:80-6.
15. Reed KL, Fruin AB, Bishop-Bartolomei KK et al. Neurokinin-1 receptor and substance P messenger RNA levels increase during intraabdominal adhesion formation. J Surg Res 2002; 108:165-72.
16. Song IS, Bunnett NW, Olerud JE et al. Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK-2R). Exp Dermatol 2000; 9:42-52.
17. Scholzen T, Armstrong CA, Bunnett NW et al. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998; 7:81-96.
18. Wagner F, Fink R, Hart R, Dancygier H. Substance P enhances interferon-gamma production by human peripheral blood mononuclear cells. Regul Pept 1987; 19:355-64.
19. Payan DG, Brewster DR, Goetzl EJ. Specific stimulation of human T lymphocytes by substance P. J Immunol 1983; 131:1613-5.
20. Ansel JC, Kaynard AK, Armstrong CA et al. Skin-nervous system interactions. J Invest Dermatol 1996; 106:198-204.
21. Ho W, Lai J, Zhu X et al. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 1997; 159:5654-60.
22. Goode T, O'Connell J, Sternini C et al. Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: molecular quantitation and localization. J Immunol 1998; 161:2232-40.
23. Stanisz AM, Scicchitano R, Dazin P et al. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J Immunol 1987; 139:749-54.
24. Lucey DR, Novak JM, Polonis VR et al. Characterization of substance P binding to human monocytes/macrophages. Clin Diagn Lab Immunol 1994; 1:330-5.
25. Shanahan F, Denburg JA, Fox J et al. Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol 1985; 135:1331-7.
26. Marriott I, Bost KL. Expression of authentic substance P receptors in murine and human dendritic cells. J Neuroimmunol 2001; 114:131-41.
27. Watanabe M, Nakayasu K, Iwatsu M, Kanai A. Endogenous substance P in corneal epithelial cells and keratocytes. Jpn J Ophthalmol 2002; 46:616-20.
28. Kemeny L, von Restorff B, Michel G et al. Specific binding and lack of growth-promoting activity of substance P in cultured human keratinocytes. J Invest Dermatol 1994; 103:605-6.
29. Staniek V, Liebich C, Vocks E et al. Modulation of cutaneous SP receptors in atopic dermatitis after UVA irradiation. Acta Derm Venereol (Stockh) 1998; 78:92-4.
30. Fristad I, Vandevska-Radunovic V, Kvinnsland IH. Neurokinin-1 receptor expression in the mature dental pulp of rats. Arch Oral Biol 1999; 44:191-5.
31. Kavelaars A, Jeurissen F, Frijtag V et al. Substance P induces a rise in intracellular calcium concentration in human T lymphocytes in vitro: evidence of a receptor-independent mechanism. J Neuroimmunol 1993; 42:61-70.